Literature DB >> 9486052

Primary choriocarcinoma of the pulmonary artery mimicking pulmonary embolism.

J Trübenbach1, P L Pereira, P E Huppert, C Farnsworth, R Mayer, U Feine, C D Claussen.   

Abstract

Due to their rarity, primary tumours of the pulmonary arteries are often incorrectly diagnosed as more common diseases such as pulmonary thromboembolism and are seldom diagnosed during a patient's lifetime. Surgery or potentially curative chemotherapy may therefore be withheld. We report a patient with a primary choriocarcinoma of the left pulmonary artery, which was first suspected on a CT scan. The neoplastic nature of the obstruction of the pulmonary arteries was confirmed by positron emission tomography.

Entities:  

Mesh:

Year:  1997        PMID: 9486052     DOI: 10.1259/bjr.70.836.9486052

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  4 in total

1.  The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study.

Authors:  Ting Chang Chang; Tzu Chen Yen; Yiu Tai Li; Yen Ching Wu; Yu Cheng Chang; Koon Kwan Ng; Shih Ming Jung; Tzu I Wu; Chyong Huey Lai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

2.  Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.

Authors:  P Mapelli; G Mangili; M Picchio; C Gentile; E Rabaiotti; V Giorgione; E G Spinapolice; L Gianolli; C Messa; M Candiani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

3.  Primary renal artery choriocarcinoma causing secondary renovascular hypertension.

Authors:  Taner Abdullah Usta; Tolga Karacan; Eser Ozyurek; M Murat Naki; Suat Nail Omeroglu; Fuat Demirkiran
Journal:  Int J Surg Case Rep       Date:  2014-11-20

4.  Choriocarcinoma-associated pulmonary thromboembolism and pulmonary hypertension: a case report.

Authors:  Yan Zhu; Meining Yu; Luyao Ma; Hai Xu; Fanghong Rose Li
Journal:  J Biomed Res       Date:  2015-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.